Shavon Williams, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 611 East Hampton Street, Anderson, South Carolina, SC 29624 Phone: 864-226-5054 Fax: 864-226-5643 |
News Archive
PIKAMAB, a biopharmaceutical company specializing in stratified medicine, announced today that it has been awarded two grants by the U.S. Government under the QTDP program to advance the development and commercialization of two theragnostic products: ADCC Therasight and Lupus Therasight. PIKAMAB applied for two grants, both of which qualified and received the maximum grant amounts totaling approximately $488,959.
Type 2 diabetes and its complications are frequently diagnosed too late and the complications are often detected only at the time of diagnosis, concludes the European Parliament in its 2006 Written Declaration on Diabetes.
NeuroDerm, Ltd. announced today that enrollment of healthy subjects is ongoing in its Phase I clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously via a subcutaneous delivery patch device. It is designed to provide steady levodopa blood levels and enhanced bioavailability of oral levodopa for the reduction of motor complications in Parkinson's disease.
A memo circulated by Sen. Judd Gregg, R-N.H., spells out the arsenal of parliamentary maneuvers available to Republicans as they seek to stall the Senate's health debate, The New York Times reports on its Prescriptions blog. Gregg has a reputation as one of the GOP's "foremost experts on legislative war games."
› Verified 3 days ago